Mycosis Fungoides
What's New
Last Posted: Jun 28, 2023
- Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome.
Yumiko Hashida, et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2023 0 105523 - Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms.
Avgeros Chrysostomos, et al. International journal of molecular sciences 2023 0 (1) - Comprehensive cancer-related gene analysis reveals that active KRAS mutation is a prognostic mutation in mycosis fungoides.
Yanagi Teruki, et al. Journal of dermatological science 2017 0 (3) 367-370 - Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseases.
Gruber-Wackernagel Alexandra, et al. Photodermatology, photoimmunology & photomedicine 2018 0 (2) 100-105 - Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.
Bastidas Torres Armando N, et al. Genes, chromosomes & cancer 2018 0 (12) 653-664 - Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
Gao Yumei, et al. The Journal of investigative dermatology 2020 0 (3) 607-618.e6 - Cyclooxygenase-2 Gene Polymorphisms - 765G>C and -1195A>G and Mycosis Fungoides.
Joob Beuy, et al. Dermatology (Basel, Switzerland) 2020 0 (4) 323 - Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation.
Wobser Marion, et al. Cancers 2021 0 (21) - Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.
Jones Christine L, et al. Scientific reports 2021 0 (1) 3962 - Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility.
Ko?kowski Karol, et al. Acta dermato-venereologica 2022 9 adv00777 - Cyclooxygenase-2 Gene Polymorphisms -765G>C and -1195A>G and Mycosis Fungoides Risk.
Sayed Khadiga Sayed, et al. Dermatology (Basel, Switzerland) 2019 12 1-5 - Interleukin-33 polymorphisms and serum concentrations in mycosis fungoides.
Rustowska-Rogowska Alicja, et al. International journal of dermatology 2019 10 - Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.
Cabello Irene, et al. JAMA dermatology 2018 12 (12) 1424-1431 - Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.
Incel Uysal Pinar, et al. Acta dermatovenerologica Croatica : ADC 2018 4 (1) 8-14 - Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter Ofer, et al. Archives of dermatological research 2017 9 - TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.
Wooler Gitte, et al. Frontiers in medicine 2016 0 51 - Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study.
Rasheed Hoda, et al. PloS one 2016 0 (6) e0158014 - Analysis of differential ß variable region of T cell receptor expression and NAV3/TNFRSF1B gene mutation in mycosis fungoides.
Hongzhou Cui, et al. Oncotarget 2016 2 - Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease.
Malek Marta, et al. Acta dermato-venereologica 2015 3 (3) 283-8 - Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.
Brazzelli V, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2015 3
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: